Drug delivery, formulation

Symbiosis expands sterile manufacturing with new facility and innovations

02-Oct-2024 By Liza Laws

As CPHI Milan 2024 approaches, Symbiosis Pharmaceutical Services is gearing up to showcase major expansions and innovations in sterile biopharmaceutical manufacturing.

SGD Pharma to showcase new glass packaging solutions at CPHI 2024

02-Oct-2024 By Liza Laws

The company will introduce its innovative siliconized moulded glass vials, positioning itself as the only global supplier offering this technology to pharmaceutical standards.

Insilico Medicine claims phase 2 win for AI-designed drug

19-Sep-2024 By By Helen Albert

The Hong Kong headquartered company says its idiopathic pulmonary fibrosis drug performed well in a phase 2a trial and met its primary endpoint.

F2G raises $100 million to combat innovation 'paucity' in antifungals

17-Sep-2024 By Jonathan Smith

One year after a rejection by the US Food and Drug Administration (FDA), the UK firm F2G has raised $100 million to push its candidate olorofim to the market for the treatment of rare fungal infections in 2026.

Metagenomics revolution: Empress Therapeutics on drug discovery breakthroughs

03-Sep-2024 By Liza Laws

Dr Dawn Thompson has over 20 years of experience in building technology platforms that leverage genomics at scale to produce novel products.

ALZpath and Beckman Coulter partner for breakthrough diagnostic

27-Aug-2024 By Liza Laws

In the ongoing battle against Alzheimer’s disease, early diagnosis is crucial.

Lonza boosts clinical services with new bottling capabilities

15-Aug-2024 By Liza Laws

Lonza, a global leader in the pharmaceutical, biotech, and nutraceutical markets, has announced a significant expansion of its clinical manufacturing services at its small molecules site in Bend, Oregon.

How nuVizz transforms pharma supply chains: Insights from its CEO, Guru Rao

14-Aug-2024 By Liza Laws

In the ever-evolving world of pharmaceutical logistics, nuVizz has emerged as a key player, delivering innovative solutions that streamline the delivery management process.

Certa’s CEO Jag Lamba on enhancing pharma supply chain traceability and compliance

14-Aug-2024 By Liza Laws

In an increasingly complex regulatory landscape, pharmaceutical companies face significant challenges in maintaining transparency and accountability across their global supply chains.

Improving clinical supply chains: An in-depth conversation with IQVIA's Stefan Duerr

14-Aug-2024 By Liza Laws

In the intricate world of clinical trials, the integrity and efficiency of the drug supply chain are paramount.

PLAIO raises €4.3M to revolutionize pharma supply chains with AI-driven planning platform

12-Aug-2024 By Liza Laws

In a landmark move for the pharmaceutical industry, PLAIO, a pioneering Icelandic tech firm, has secured €4.3 million in an oversubscribed funding round to accelerate its AI-driven sales and operations planning platform designed specifically for the pharmaceutical...

Bruker acquires stake in NovAliX, an alliance to revolutionize drug discovery

08-Aug-2024 By Liza Laws

In a significant move set to reshape the landscape of drug discovery, NovAliX, a leading Contract Research Organization (CRO) specializing in drug development, has entered a strategic partnership with Bruker, a global leader in scientific instruments.

Innovation revenue exceeds generics for the first time in company history

01-Aug-2024 By Liza Laws

Piramal Pharma Solutions, a leading Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd., has achieved an historic milestone.

Revolutionary Alzheimer's drug donanemab approved – what does this mean for the future of care?

26-Jul-2024 By Liza Laws

The approval of donanemab marks a significant breakthrough in Alzheimer's treatment, promising transformative changes in patient care and research.

FDA approves Rusan Pharma’s manufacturing facility in India, paving the way for expanded US presence

23-Jul-2024 By Liza Laws

Rusan Pharma Private Limited has announced that its active pharmaceutical ingredient (API) manufacturing facility in Ankleshwar, Gujarat, has been granted Good Manufacturing Practice (GMP) approval by the FDA.

Apollo Therapeutics and University of Oxford collaborate to revolutionize drug development

22-Jul-2024 By Liza Laws

Apollo Therapeutics and the University of Oxford have embarked on a collaborative journey in drug discovery and development.

Roche’s oral GLP-1 receptor agonist shows promising early weight loss results in phase 1

18-Jul-2024 By Helen Albert

Roche’s recent $2.7 billion acquisition of Carmot Therapeutics is paying off, with positive results for new oral GLP-1 receptor agonist.

Nipro's $397.8M investment brings 232 new jobs to Greenville, NC with exciting new facility

18-Jul-2024 By Liza Laws

Japanese medical devices company, Nipro Medical Corporation, a giant in the healthcare and medical device industry, has announced a major investment of $397.8 million to establish its first North American manufacturing center of excellence in Greenville,...

Psychedelic drug investments surge in 2024: Key startups raising funds and closing deals

16-Jul-2024 By Clara Rodriguez Fernandez

Psychedelic therapeutics have rapidly gained popularity in the pharma industry in a matter of just a few years. Here are five psychedelic drug discovery startups that have received investment this year.

Celadon Pharmaceuticals celebrates eighth harvest, poised for 15 a year

16-Jul-2024 By Liza Laws

Today (July 16) Celadon Pharmaceuticals Plc, a trailblazer in the UK’s pharmaceutical industry, has achieved a significant milestone with the successful completion of its eighth cannabis harvest of 2024.

Women in Science - Jasmina Jankicevic from founding organizations for the prevention of HIV to CMO at Innovaderm Research

15-Jul-2024 By Liza Laws

During her teenage years, Dr. Jasmina Jankicevic harbored a passion for researching and advocating improved methods to maintain health and well-being for both children and adults.

Novo Nordisk announces $4.1BN investment to expand US manufacturing capacity

12-Jul-2024 By Liza Laws

Novo Nordisk has revealed plans for a $4.1 billion investment in a new manufacturing facility in Clayton, North Carolina.

The top 5 emerging startups fuelling drug discovery with AI

27-Jun-2024 By Liza Laws

Artificial intelligence is showing great promise in the quest to unearth new drug candidates and disease targets faster than ever before.

Novo Nordisk announces $4.1BN investment to expand US manufacturing capacity

25-Jun-2024 By Liza Laws

Yesterday (June 24) Novo Nordisk unveiled plans to invest $4.1 billion (approximately €3.8 billion) in a new manufacturing facility in Clayton, North Carolina.

NIH awards Cellibre $2M to advance sustainable cannabinoid ingredient production

18-Jun-2024 By Liza Laws

Cellibre, a pioneer in sustainable biochemical manufacturing, has received a $2 million grant from the National Center for Complementary and Integrative Health (NCCIH) at the National Institutes of Health (NIH).

Incorporating behavioral science: A new approach to patient-focused drug development?

18-Jun-2024 By Liza Laws

Is it time to incorporate behavioral science into early drug design and development, in pursuit of a truly patient-focused approach from day one?

IGC Pharma - unlocking new horizons in Alzheimer’s care with personalized medicine

11-Jun-2024 By Liza Laws

Yesterday (June 10) IGC Pharma, Inc. announced the publication of groundbreaking research in the European Society of Medicine Journal.

Systech unveils game-changing turnkey solution for pharma rework and aggregation

10-Jun-2024 By Liza Laws

In a groundbreaking development, Systech, a subsidiary of Markem-Imaje and Dover, has introduced a turnkey manual aggregation and rework solution tailored for pharmaceutical manufacturers, CMOs, CDMOs, re-packagers, and wholesalers.

Sonara Health: Transforming methadone treatment access for opioid use disorder patients

10-Jun-2024 By Liza Laws

In an inspiring conversation with Liza Laws, Dr. Michael Giles, MD, and chief executive officer of Sonara Health, shares the innovative journey of creating a platform to enhance the accessibility of methadone treatment for opioid use disorder patients.

Does Stardog AI hold the key to faster pharma success?

06-Jun-2024 By Liza Laws

In today's fast-paced pharmaceutical industry, major players are seeking innovative solutions to accelerate the drug development process.

Roquette's US innovation center marks first year of pharmaceutical advancements

06-Jun-2024 By Liza Laws

As Roquette's US Innovation Center marks its first anniversary, Roquette took the opportunity to reflect on its interesting journey and achievements over the past year.

Asahi Kasei's $1.1 billion power move - acquiring Calliditas to dominate global healthcare

30-May-2024 By Liza Laws

In a bold move set to reshape the global healthcare landscape, Asahi Kasei Corp. announced its intent to acquire Swedish drug maker Calliditas Therapeutics AB through a voluntary tender offer.

Bicycle Therapeutics secures $555M in private placement equity financing

28-May-2024 By Liza Laws

This funding round includes participation from both new and existing accredited investors, reinforcing confidence in Bicycle's innovative approach to precision-guided therapeutics.

Roquette solving toughest drug development challenges with new capsules

14-May-2024 By Liza Laws

Roquette, a global leader in plant-based ingredients and a key provider of pharmaceutical and nutraceutical excipients, announced today (May 14) the launch of its innovative Lycagel Flex hydroxypropyl pea starch premix for softgel capsules.

Shionogi and Maze seal worldwide exclusive in bid to cure Pompe disease

10-May-2024 By Liza Laws

In an interesting development in the field of rare disease therapeutics, Shionogi & Co., Ltd., and Maze Therapeutics, Inc. have sealed an exclusive worldwide license agreement for MZE001, a novel therapeutic candidate aimed at tackling Pompe disease.

Report highlights challenges facing life sciences sector amid economic turbulence

09-May-2024 By Liza Laws

A collaborative report released today (May 9) by Medicines Discovery Catapult (MDC), sheds light on the challenges facing the life sciences sector amidst recent economic turbulence.

PCI Pharma initiates installation of $100M isolator-based sterile fill-finish site

07-May-2024 By Liza Laws

PCI Pharma Services, a global leader in contract development and manufacturing, has embarked on the installation of crucial equipment for its latest sterile fill-finish facility at its Bedford, NH campus in Philadelphia.

Walgreens to be used as clinical trial sites focusing on obesity and type 2 diabetes

07-May-2024 By Liza Laws

Walgreens and Boehringer Ingelheim have joined forces in a move to enhance diversity and accessibility in clinical trials, aiming to make participation more inclusive and equitable.

Lonza integrates advanced technology to simplify synthetic route identification for novel APIs

30-Apr-2024 By Liza Laws

Yesterday (April 29), Lonza, a global partner in the pharmaceutical, biotech, and nutraceutical sectors, announced the introduction of its AI-enabled Route Scouting Service (RSS).

Quotient Sciences new platform disrupts conventional drug development processes

23-Apr-2024 By Liza Laws

At CPhI North America, Quotient Sciences is looking forward to reconnecting with its customers and giving them a preview of how we are looking to expand Translational Pharmaceutics further within the US.

Catching up with LGM Pharma ahead of CPhI North America to find out about its pipeline

19-Apr-2024 By Liza Laws

LGM Pharma is a leading CDMO provider of comprehensive API sourcing and drug product contract development and manufacturing solutions to the pharmaceutical, biotechnology, and compounding pharmacy industries.

DCAT 2024

Bormioli Pharma leading the way with sustainable pharmaceutical packaging

17-Apr-2024 By Liza Laws

Bormioli Pharma creates pharmaceutical packaging for drug stability, safety, and sustainability, partnering with global health leaders and says it stands at the forefront of sustainability.

Qinecsa Solutions acquires Insife to strengthen pharmacovigilance technology

16-Apr-2024 By Liza Laws

Qinecsa Solutions (Qinecsa), a lead company in technology-driven end-to-end pharmacovigilance solutions has announced its acquisition of Insife ApS (Insife), a Danish-based firm specializing in innovative pharmacovigilance platforms.

Innovating drug development: Charles River embracing alternatives to animal testing

16-Apr-2024 By Liza Laws

Charles River Laboratories International, Inc. has unveiled its Alternative Methods Advancement Project (AMAP), a strong initiative aimed at changing drug discovery and development by exploring alternatives to animal testing.

DCAT

Outsourcing-Pharma

Resources